Office of Medical Communications

As the COVID-19 pandemic continues to bear down on the world, University of Vermont Larner College of Medicine alums are at the front line treating patients and protecting public health.

The American Academy of Arts & Sciences has announced the election of University of Vermont Professor of Microbiology and Molecular Genetics Emerita Susan Wallace, Ph.D., to its membership, in recognition of her status as a world leader in the sciences. Wallace joins 275 new members elected on April 23, 2020.

UVM Professor Harold Dauerman, M.D., and other representatives of the American College of Cardiology, American College of Emergency Physicians and Society of Cardiovascular Angiography & Interventions, issued guidlines to help clinicians make decisions about treatment alternatives for heart attack patients in the environment of the novel coronavirus pandemic.

(APRIL 24, 2019) Stephen Higgins, Ph.D., professor of psychiatry and director of the Vermont Center on Behavior and Health at UVM, is quoted in a U.S. News & World Report article, titled "A Barren Landscape for Meth Treatment."

We’ve seen the images: an elderly nursing home resident on the far side of a window, looking out at family members, hands pressed to the glass the only means of contact.

For first-year students, the COVID-19 pandemic has meant the interruption of active learning sessions on campus as well as the suspension of the Doctoring in Vermont course that sends students into primary care offices throughout Vermont. Karen Lounsbury, Ph.D., director of the Foundations level of the Vermont Integrated Curriculum, says faculty have stepped up to the challenge the pandemic has presented.

Over one dozen Larner College of Medicine medical, doctoral students and Master of Public Health degree students recently presented their research alongside hundreds of peers from across UVM for the first-ever virtual Student Research Conference.

Often-deadly blood clots are a common complication of cancer care, yet less than five percent of patients receive education on how to prevent them. A team of clinician-researchers at the UVM Cancer Center have published an evidence-based prevention “roadmap” found to reduce blood clots by 38 percent in the highest-risk patients.

The launch of UVM’s first-ever Wilderness Medicine Conference last year tapped into a great enthusiasm among a wide range of medical professionals for improving medical care in remote locations. This year’s event will be an even bigger draw for “medical and interprofessional education” with the introduction of credit approval for EMTs.

(APRIL 20, 2020) Daniel Weiss, M.D., Ph.D., professor of medicine, commented on the potential for cell therapies to be effective in treating COVID-19 in an article on ClinicalTrialsArena.com, a drug development and research industry news site.

(APRIL 17, 2020) Professor of Neurological Sciences Robert Shapiro, M.D., Ph.D., was featured in a video interview for Neurology Live on gaining access to migraine treatment in light of the COVID-19 pandemic. Shapiro is an advocate for a new class of medications that are administered less frequently, which may help improve management of migraine during the pandemic.